Stockscreener 앱 받기
5.48
8.05%
-0.48
시간 외 거래:
5.58
0.10
+1.82%
전일 마감가:
$5.96
열려 있는:
$6
하루 거래량:
6.44M
Relative Volume:
1.07
시가총액:
$1.17B
수익:
$2.59M
순이익/손실:
$-137.89M
주가수익비율:
-6.7654
EPS:
-0.81
순현금흐름:
$-69.76M
1주 성능:
+0.55%
1개월 성능:
+17.85%
6개월 성능:
+285.92%
1년 성능:
+352.89%
1일 변동 폭
$5.475
$6.09
1주일 범위
$5.06
$6.30
52주 변동 폭
$1.04
$6.30
Atai Life Sciences N V Stock (ATAI) Company Profile
명칭
Atai Life Sciences N V
전화
49 89 2153 9035
주소
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
ATAI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATAI
Atai Life Sciences N V
|
5.48 | 1.40B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-13 | 개시 | Needham | Buy |
| 2025-07-29 | 개시 | Oppenheimer | Outperform |
| 2024-11-18 | 재확인 | H.C. Wainwright | Buy |
| 2024-04-03 | 업그레이드 | Maxim Group | Hold → Buy |
| 2022-11-01 | 개시 | Loop Capital | Buy |
| 2021-11-30 | 개시 | Maxim Group | Buy |
| 2021-11-11 | 개시 | ROTH Capital | Buy |
| 2021-10-18 | 개시 | H.C. Wainwright | Buy |
| 2021-09-01 | 개시 | Jefferies | Buy |
| 2021-07-13 | 개시 | Berenberg | Buy |
| 2021-07-13 | 개시 | Canaccord Genuity | Buy |
| 2021-07-13 | 개시 | Cantor Fitzgerald | Buy |
| 2021-07-13 | 개시 | Citigroup | Buy |
| 2021-07-13 | 개시 | Cowen | Outperform |
| 2021-07-13 | 개시 | Credit Suisse | Outperform |
| 2021-07-13 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | 개시 | Aegis Capital | Buy |
모두보기
Atai Life Sciences N V 주식(ATAI)의 최신 뉴스
$130M Raise: atai Life Sciences Prices 23.7M Shares at $5.48 to Fund Clinical Development - Stock Titan
atai Life Sciences Announces Pricing of Public Offering of Common Shares - Yahoo
Atai Life Sciences N.V. (ATAI) Stock Rebounds as Company Launches New Share Offering - parameter.io
ATAI Life Sciences and Beckley Psytech Announce FDA Breakthrough Therapy Designation for BPL-003 - TradingView
atai Life Sciences, Beckley Psytech get FDA breakthrough therapy status for BPL-003 - Seeking Alpha
Atai Life Sciences Gets FDA Breakthrough Designation for Depression Treatment - MarketScreener
Can swing trading help recover from Atai Life Sciences N.V. lossesQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com
Proposed common-share offering: atai Life Sciences to fund clinical programs; Jefferies lead bookrunner - Stock Titan
Atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression - MarketScreener
atai Life Sciences Receives FDA Breakthrough for BPL-003 in TRD | ATAI Stock News - Stock Titan
Combining machine learning predictions for Atai Life Sciences N.V.Trade Volume Summary & Low Drawdown Momentum Ideas - newser.com
Ranking Atai Life Sciences N.V. among high performing stocks via toolsWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com
How high can Atai Life Sciences N.V. stock goPortfolio Return Report & Community Trade Idea Sharing - newser.com
Can technical indicators confirm Atai Life Sciences N.V.’s reversal2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Atai Life Sciences N.V. stock retracement – recovery analysisInsider Buying & Daily Entry Point Trade Alerts - newser.com
Psychedelic stocks up on remarks from GOP Senator (ATAI) - Seeking Alpha
How institutional ownership impacts Atai Life Sciences N.V. stockQuarterly Profit Report & AI Enhanced Market Trend Forecasts - newser.com
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside - Sahm
Atai Life Sciences N.V. stock chart pattern explainedQuarterly Market Summary & Low Risk High Reward Trade Ideas - newser.com
Tick level data insight on Atai Life Sciences N.V. volatilityQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Quantitative breakdown of Atai Life Sciences N.V. recent moveJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - newser.com
Can Atai Life Sciences N.V. stock resist sector downturnsJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
How Atai Life Sciences N.V. (9VC) stock responds to job market shiftsGold Moves & Short-Term Trading Alerts - newser.com
Is now a turning point for Atai Life Sciences N.V.Profit Target & Verified Swing Trading Watchlists - newser.com
Needham Initiates ATAI Life Sciences N.V at Buy With $12 Price Target - MarketScreener
Needham Initiates Coverage of Atai Life Sciences N.V. (ATAI) with Buy Recommendation - Nasdaq
ATAI Life Sciences files update on Beckley Psytech acquisition plans By Investing.com - Investing.com Nigeria
ATAI Life Sciences files update on Beckley Psytech acquisition plans - Investing.com
ATAI Life Sciences to Acquire Beckley Psytech - TipRanks
ATAI Life Sciences N.V. Announces Acquisition of Beckley Psytech - TradingView
Published on: 2025-10-10 04:54:45 - newser.com
ATAI Life Sciences N.V. (ATAI) Stock Analysis: A Biotech Gem With 107% Potential Upside - DirectorsTalk Interviews
Can trapped investors hope for a rebound in Atai Life Sciences N.V.Portfolio Growth Summary & Low Risk Growth Stock Ideas - newser.com
What to expect from Atai Life Sciences N.V. in the next 30 daysJuly 2025 Selloffs & Technical Confirmation Trade Alerts - newser.com
Evaluating Atai Life Sciences N.V. with trendline analysis2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
What sentiment indicators say about Atai Life Sciences N.V. stockJuly 2025 Volume & Expert Approved Momentum Ideas - newser.com
Will Atai Life Sciences N.V. stock outperform growth indexes2025 Market WrapUp & Safe Capital Growth Tips - newser.com
How to track smart money flows in Atai Life Sciences N.V.IPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Using RSI to spot recovery in Atai Life Sciences N.V.July 2025 Intraday Action & Expert Verified Movement Alerts - newser.com
Short interest data insights for Atai Life Sciences N.V.2025 Growth vs Value & AI Powered Market Entry Strategies - newser.com
Momentum divergence signals in Atai Life Sciences N.V. chartPortfolio Growth Summary & Risk Managed Investment Signals - newser.com
Atai Life Sciences N V (ATAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.96%
0.09%
자본화:
|
볼륨(24시간):